Purdue Pharma and its owners, the Sackler family, reached a settlement of up to $7.4 billion for its role in the opioid crisis, less than a year after the Supreme Court tossed out a proposed $6 ...

Shake Shack has its sights set on massively expanding its popular burger chain. The company raised its target for company-operated restaurants in America to "at least" 1,500 in the long-term ...

You know what? Props to Breaking Benjamin, who have stayed in the either for like two decades. They’re finally back again with some new music—their first since 2018’s Ember—in the form of a new single ...

The deal comes after the US Supreme Court last year rejected a $6 billion pact that would have protected Purdue’s owners, members of the billionaire Sackler family, from any further litigation ...

Shake Shack (SHAK) posted preliminary fourth quarter results that beat expectations, but investors don't seem convinced. Shares of the fast-casual chain fell 6% on Monday after the company ...

If one is not reached, it could open the floodgates to lawsuits against Sackler family members.The new settlement could bring to a close a chapter in a long legal saga over the toll of an opioid ...

The Polish government has adopted a resolution promising that senior Israeli officials – including Prime Minister Benjamin Netanyahu – can freely travel to Poland for the 80th anniversary of ...

Massachusetts could receive more than $100 million as part of a tentative new settlement between attorneys general, Purdue Pharma and the company’s controlling Sackler family that reshapes some of the ...

Purdue Pharma, the makers and marketers of the highly addictive opioid OxyContin, and the family that owned the company, the Sackler family, have agreed to pay $7.4 billion to individuals ...

Purdue Pharma, the makers and marketers of the highly addictive opioid OxyContin, and the family that owned the company, the Sackler family, have agreed to pay $7.4 billion to individuals, states, ...

Shares of fast-food chain Shake Shack (NYSE:SHAK) fell 8.1% in the afternoon session after the company reported underwhelming preliminary sales outlook for Q4 2024, barely surpassing Wall Street's ...